David P. Southwell - Jun 18, 2025 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director
Signature
/s/ Martin Wilson, as attorney-in-fact for David Southwell
Stock symbol
RCKT
Transactions as of
Jun 18, 2025
Transactions value $
$0
Form type
4
Date filed
7/18/2025, 04:05 PM
Previous filing
Jan 7, 2025
Next filing
Sep 11, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SOUTHWELL DAVID P Director C/O ROCKET PHARMACEUTICALS, INC., 9 CEDARBROOK DRIVE, CRANBURY /s/ Martin Wilson, as attorney-in-fact for David Southwell 2025-07-18 0001251553

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Award $0 +30K +1807.23% $0.00 31.7K Jun 18, 2025 Direct F1
holding RCKT Common Stock 113K Jun 18, 2025 By The David P. Southwell Irrevocable Trust Dtd 04/14/2024
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represent restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026.